deltatrials
Unknown OBSERVATIONAL NCT04755829

Breath Test to Predict Breast Cancer and Outcome of Mammography

Sponsor: Menssana Research, Inc.

Conditions Abnormal Mammogram, Unspecified Breast Cancer
Interventions BreathX test for breath VOCs
Updated 4 times since 2021 Last updated: Feb 12, 2021 Started: Mar 31, 2021 Primary completion: Mar 31, 2023 Completion: Mar 31, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Abnormal Mammogram, Unspecified and Breast Cancer, this trial is ongoing. The trial is conducted by Menssana Research, Inc. and has accumulated 4 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Mar 2021 – ~Apr 2023 · 25 months · monthly snapshotNot Yet Recruiting~Apr 2023 – ~Jul 2024 · 15 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown Status → Unknown

  3. Apr 2023 — Jul 2024 [monthly]

    Unknown Status

    Status: Not Yet Recruiting → Unknown Status

  4. Mar 2021 — Apr 2023 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Menssana Research, Inc.
  • Mount Vernon Cancer Centre
  • University of Erlangen-Nürnberg
  • Zuyderland Medical Centre
Data source: Menssana Research, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations